Challenges and advances in antimicrobial peptide development

Kamila Botelho Sampaio de Oliveira1, Michel Lopes Leite2, Victor Albuquerque Cunha1

  • 1Centro de Análises Proteômicas e Bioquímicas, Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, Brazil.

Insights

Antimicrobial peptides (AMPs) show promise for treating infections, offering a broad-spectrum alternative to conventional drugs. Strategies like novel peptide designs and nanoformulations are being developed to address challenges such as metabolic instability and toxicity for clinical use.

Area of Science:

  • Microbiology
  • Pharmacology
  • Biotechnology

Background:

  • Antimicrobial resistance (AMR) is a significant global public health threat.
  • Inappropriate antimicrobial use drives the development of resistance.
  • Antimicrobial peptides (AMPs) are a potential therapeutic alternative due to their broad-spectrum activity.

Purpose of the Study:

  • To describe AMPs as promising molecules for novel antimicrobial drug development.
  • To outline current strategies for overcoming AMPs' clinical application challenges.
  • To highlight the potential of AMPs in combating infectious diseases.

Main Methods:

  • Review of current literature on AMPs.
  • Analysis of strategies for enhancing AMP stability and reducing toxicity.
  • Exploration of nanoformulation techniques for AMP delivery.

Main Results:

  • AMPs possess broad-spectrum antimicrobial properties.
  • Metabolic instability and toxicity are key challenges for AMP clinical application.
  • Peptide design modifications and nanoformulations show potential for overcoming these hurdles.

Conclusions:

  • AMPs represent a promising class of molecules for developing new antimicrobial therapies.
  • Advanced design and formulation strategies are crucial for successful clinical translation of AMPs.
  • Further research into AMPs is warranted to combat the growing threat of antimicrobial resistance.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
1.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
77
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
50
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
49